Showing results (61-70 of 252) with videos related to
Sort By:
Pageof 26
Expert Opinion on Drug Safety|October 5, 2017
Drugs approved for the treatment of multiple sclerosis: review of their safety profileFabiana Auricchio, Cristina Scavone, Daniela Cimmaruta, et al.Expert Opinion on Drug Safety|April 17, 2025
Hepatobiliary disorders and Direct-Acting Antiviral (DAA) therapies: real-world evidence and insights from the EudraVigilance databaseJohn Scicluna, Raffaella Di Napoli, Daniele Pirozzi, et al.Expert Opinion on Drug Safety|December 19, 2024
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)Raffaella Di Napoli, Nunzia Balzano, Rosanna Ruggiero, et al.Journal of Personalized Medicine|September 28, 2024
Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance DatabaseNunzia Balzano, Annamaria Mascolo, Raffaella Di Napoli, et al.Pharmaceutics|December 23, 2023
Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in ItalySara Mucherino, Concetta Rafaniello, Marianna Serino, et al.Journal of Pharmacology & Pharmacotherapeutics|August 28, 2015
Complete resistance after maximal dose of rocuroniumAnnalisa Capuano, Maria Giuseppa Sullo, Concetta Rafaniello, et al.Vaccines|February 28, 2023
Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild StudyAlessia Zinzi, Mario Gaio, Valerio Liguori, et al.Expert Review of Clinical Pharmacology|October 5, 2022
Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19Rosanna Ruggiero, Nunzia Balzano, Raffaella Di Napoli, et al.Plos One|July 29, 2016
Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort StudyMaurizio Sessa, Annamaria Mascolo, Mikkel Porsborg Andersen, et al.Rivista Di Psichiatria|July 1, 2016
[Drug safety warnings in psychiatry: adverse drug reactions' signaling from 2002 to 2014]Vincenzo Prisco, Teresa Iannaccone, Adriano Tusciano, et al.Pageof 26